Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $17.99, or
get to entire website for at least 3 months from $49.99.
Bristol-Myers Squibb Co. (BMY)
Profitability Analysis
Quarterly Data
Difficulty: Beginner
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Ratios (Summary)
Bristol-Myers Squibb Co., profitability ratios (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Bristol-Myers Squibb Co.’s gross profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Bristol-Myers Squibb Co.’s operating profit margin improved from Q2 2018 to Q3 2018 but then deteriorated significantly from Q3 2018 to Q4 2018. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Bristol-Myers Squibb Co.’s net profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Bristol-Myers Squibb Co.’s ROE improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Bristol-Myers Squibb Co.’s ROA improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Gross Profit Margin
Bristol-Myers Squibb Co., gross profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
Q4 2018 Calculations
1 Gross profit margin = 100
× (Gross marginQ4 2018
+ Gross marginQ3 2018
+ Gross marginQ2 2018
+ Gross marginQ1 2018)
÷ (RevenuesQ4 2018
+ RevenuesQ3 2018
+ RevenuesQ2 2018
+ RevenuesQ1 2018)
= 100
× ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Bristol-Myers Squibb Co.’s gross profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Operating Profit Margin
Bristol-Myers Squibb Co., operating profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
Q4 2018 Calculations
1 Operating profit margin = 100
× (Operating incomeQ4 2018
+ Operating incomeQ3 2018
+ Operating incomeQ2 2018
+ Operating incomeQ1 2018)
÷ (RevenuesQ4 2018
+ RevenuesQ3 2018
+ RevenuesQ2 2018
+ RevenuesQ1 2018)
= 100 × ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Bristol-Myers Squibb Co.’s operating profit margin improved from Q2 2018 to Q3 2018 but then deteriorated significantly from Q3 2018 to Q4 2018. |
Net Profit Margin
Bristol-Myers Squibb Co., net profit margin calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
Q4 2018 Calculations
1 Net profit margin = 100
× (Net earnings (loss) attributable to BMSQ4 2018
+ Net earnings (loss) attributable to BMSQ3 2018
+ Net earnings (loss) attributable to BMSQ2 2018
+ Net earnings (loss) attributable to BMSQ1 2018)
÷ (RevenuesQ4 2018
+ RevenuesQ3 2018
+ RevenuesQ2 2018
+ RevenuesQ1 2018)
= 100 × ( + + + )
÷ ( + + + )
=
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Bristol-Myers Squibb Co.’s net profit margin improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Return on Equity (ROE)
Bristol-Myers Squibb Co., ROE calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
Q4 2018 Calculations
1 ROE = 100
× (Net earnings (loss) attributable to BMSQ4 2018
+ Net earnings (loss) attributable to BMSQ3 2018
+ Net earnings (loss) attributable to BMSQ2 2018
+ Net earnings (loss) attributable to BMSQ1 2018)
÷ Total Bristol-Myers Squibb Company shareholders’ equity
= 100 × ( + + + )
÷ =
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Bristol-Myers Squibb Co.’s ROE improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |
Return on Assets (ROA)
Bristol-Myers Squibb Co., ROA calculation (quarterly data)
Based on: 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).
Q4 2018 Calculations
1 ROA = 100
× (Net earnings (loss) attributable to BMSQ4 2018
+ Net earnings (loss) attributable to BMSQ3 2018
+ Net earnings (loss) attributable to BMSQ2 2018
+ Net earnings (loss) attributable to BMSQ1 2018)
÷ Total assets
= 100 × ( + + + )
÷ =
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Bristol-Myers Squibb Co.’s ROA improved from Q2 2018 to Q3 2018 and from Q3 2018 to Q4 2018. |